One of the main serine-threonine phosphatases, PP2A, plays a tumor-suppressive role, as it is often genetically altered or functionally inactivated in numerous solid cancers and leukemia, leading to the promotion of tumor progression through inhibition of PP2A activity (51). The gene discussed is PTPA; the disease is leukemia.